Press release
Neuropsychiatric Drug Market Revenue Growth and Challenges Impacting Adoption Rates by 2031
Neuropsychiatric Drugs Market
The Neuropsychiatric Drugs Market is expected to grow at a 4.5 % CAGR during the forecast period for 2023-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1170
Neuropsychiatric disorders encompass a wide spectrum of medical conditions that bridge the fields of neurology and psychiatry, arising from dysfunctions within the cerebral system. These disorders are predominantly observed in pediatric and adolescent populations. Although numerous pharmaceutical treatments exist for various stages of neuropsychiatric conditions, a significant proportion of these medications have yet to undergo comprehensive testing in children.
The global demand for neuropsychiatric drugs is anticipated to grow substantially over the forecast period, driven by factors such as the high prevalence of neuropsychiatric disorders worldwide, an increasing need for cost-effective therapeutic options, expanding drug development pipelines, ongoing innovations in advanced treatment modalities, and intensified research and development efforts focused on novel drug candidates.
According to the World Health Organization (WHO), depression ranks among the leading causes of disability globally, affecting approximately 264 million individuals. The rising incidence of depression and related mental health disorders is expected to create significant market growth opportunities in the coming years.
However, challenges such as the requirement for long-term treatment regimens and adverse side effects associated with neuropsychiatric medications, including blurred vision and insomnia, may hinder broader market adoption.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04
Regionally, North America is projected to maintain the largest market share throughout the forecast period (2020-2030), followed by Europe. This dominance is attributed to heightened mental health awareness, a well-developed healthcare infrastructure, and substantial investments in research and development aimed at advancing novel treatments for neuropsychiatric disorders.
Major market players operating in the neuropsychiatric drugs market include Novartis (Switzerland), Pfizer (US), Otsuka (Japan), Allergan (Ireland), Eli Lilly (US), Sunovion (US), AstraZeneca (UK), Actavis Laboratories (US), Johnson & Johnson (US), Bristol Myers (US), Sage Therapeutics (US), BlackThorn Therapeutics (US), H. Lundbeck A/S (Denmark), Takeda (Japan), Cerevel Therapeutics, LLC (US) among others.
Some of the key developments in the market:
• In September 2021, Otsuka Pharmaceutical (Japan) and Sunovion (US), a subsidiary of Sumitomo, collaborated to develop and commercialize four clinical-stage neuropsychiatric compounds (ulotaront, non-racemic ratio of amisulpride enantiomers, SEP-378614, and SEP-380135). These four compounds are designed to treat psychiatric diseases.
• In June 2021, Eli Lilly Alzheimer's drug received breakthrough status from the FDA. The company has plans to submit a biologics license application (BLA) for donanemab under the accelerated approval pathway later this year based on data from TRAILBLAZER-ALZ.
• In March 2019, Novartis (Switzerland) received FDA approval for Mayzent (siponimod), the first oral drug to treat relapsing forms of multiple sclerosis (RMS).
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1170
Market Segments
Global Neuropsychiatric Drugs Market, by Drug Type, 2020-2030 (Value US$ Mn)
• Typical Antipsychotics
o Prochlorperazine
o Haloperidol
o Others
• Atypical Antipsychotics
o Aripiprazole
o Asenapine
o Cariprazine
o Clozapine
o Lurasidone
o Olanzapine
o Risperidone
o Others
Global Neuropsychiatric Drugs Market, by Indication, 2020-2030 (Value US$ Mn)
• Schizophrenia
• Bipolar Disorder
• Psychotic Depression
• Others
Global Neuropsychiatric Drugs Market, by Route of Administration, 2020-2030 (Value US$ Mn)
• Oral
• Parenteral
Global Neuropsychiatric Drugs Market, by Region, 2020-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Neuropsychiatric Drugs Market, by Country, 2020-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Neuropsychiatric Drugs Market, by Country, 2020-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Neuropsychiatric Drugs Market, by Country, 2020-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Neuropsychiatric Drugs Market, by Country, 2020-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Neuropsychiatric Drugs Market, by Country, 2020-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Why should buy this report:
• To receive a comprehensive analysis of the prospects for the global neuropsychiatric drugs market
• To receive an industry overview and future trends of the neuropsychiatric drugs market
• To analyze the neuropsychiatric drugs market drivers and challenges
• To get information on the neuropsychiatric drugs market value (US$ Mn) forecast to 2030
• Significant investments, mergers & acquisitions in the neuropsychiatric drugs market industry
Read Overview Report- https://www.insightaceanalytic.com/report/global-neuropsychiatric-drugs-market-/1170
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuropsychiatric Drug Market Revenue Growth and Challenges Impacting Adoption Rates by 2031 here
News-ID: 4027611 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Smartphone Operated/Next-Generation Glucose Monitor Market expected to Witness H …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Smartphone Operated/Next-Generation Glucose Monitor Market- by Components (Diabetes Monitoring Devices, Tracking & Diagnosis Apps, iOS, Android Based and Kit Accessories), Applications (Single-Use and Dual-Use), End-Users (Home Settings, Hospital & Other Healthcare Settings and Other End Users), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the global …
Sustainable Feed & Nutrition for Aquaculture Market Survey Detailed Analysis and …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Sustainable Feed & Nutrition for Aquaculture Market By Feed Type (Algae, Insect, Single Cell Protein) Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest market research, the global Sustainable Feed & Nutrition for Aquaculture Market Size is valued at USD 7.0 Billion in 2024 and is predicted to reach USD 20.6 Billion…
Neoantigen Peptides Manufacturing Market Set to Witness Robust CAGR Growth Due t …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Neoantigen Peptides Manufacturing Market by Scale of operations (Research/Preclinical, Clinical, Commercial), by End-Users (Pharmaceutical/Vaccine developers companies, Contract Research Organizations (CRO), Academic and Research Institutes)- Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the global Neoantigen Peptides Manufacturing market is expected to grow with CAGR of 16.4%…
Smart Feminine Care Market Top Players - Orchyd, Conceivable Inc, Ava Science, I …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Smart Feminine Care Market- by Types (Products (Smart Tampons, Smart Menstrual Pads, Smart Menstrual Cups, and Fertility/Ovulation monitoring Devices/Bands) and Tracking Apps/Software), Applications (Fertility, and Other Applications), End-Users (Supermarket, General Store, Retail Pharmacies, and E-Commerce Platforms), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the global Smart…
More Releases for Neuropsychiatric
New Study Offers Detailed Insights on Paediatric Neuropsychiatric Disorders Trea …
Neuropsychiatry is concerned with study of mental disorders of nervous system that arises from overt function of cerebral system. Paediatric neuropsychiatry is a clinical discipline pertaining to the study of diagnosis and treatment of behavioural and psychiatric disorders in infants, children and adolescents. There are several factors which are hampering the functions of nervous system and cerebral function that lead to paediatric neuropsychiatric diseases. Paediatric neuropsychiatric disorders mainly caused due…
Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Researchmoz added Most up-to-date research on "Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017" to its huge collection of research reports.
Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Summary
This report provides an overview of the pipeline landscape for neuropsychiatric disorders. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Attention Deficit Hyperactivity Disorder (ADHD), Depression, Schizophrenia, and Tourette syndrome, and features dormant…
Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Attention deficit hyperactivity disorder (ADHD) is a group of behavioral symptoms that include inattentiveness, hyperactivity and impulsiveness, with symptoms including disorganized work habits, procrastination and inability to sustain attention on tasks or activities.
Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest. Signs and symptoms include sleep disturbances, including insomnia or sleeping too much, changes in appetite, anxiety, agitation or restlessness and physical problems,…
Neuropsychiatric Disorders And Treatment Market: Sturdy Expansion CAGR of 6.2% b …
Market Research Future published a research report on “Neuropsychiatric Disorders And Treatment Market Research Report- Global Forecast To 2023” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.
Global Neuropsychiatric Disorders And Treatment Market Research Report, By Disorders (Degenerative Diseases, Neurotic Disorders, Psychosis And Others), By Treatments (Shock Treatment, Drug Treatment, Others) By End Users (Hospitals, Clinics, Research Centers And Others) - Forecast Till 2023
Market Scenario:
Neuropsychiatric is the…
Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017 | Now A …
Researchmoz added Most up-to-date research on "Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017" to its huge collection of research reports.
This report provides an overview of the pipeline landscape for neuropsychiatric disorders. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Attention Deficit Hyperactivity Disorder (ADHD), Depression, Schizophrenia, and Tourette syndrome, and features dormant and discontinued projects.
To Get Sample Copy of…
Neuropsychiatric Disorder Cluster Drug Development Pipeline Review and Therapeut …
Market Research Hub includes new market research report "Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017" to its huge collection of research reports.
This report provides an overview of the pipeline landscape for neuropsychiatric disorders. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Attention Deficit Hyperactivity Disorder (ADHD), Depression, Schizophrenia, and Tourette syndrome, and features dormant and discontinued projects.
Request Free Sample…
